ARTICLE | Company News
Genzyme Molecular in drug discovery with Purdue
October 18, 2000 7:00 AM UTC
GZMO and Purdue Pharma (Stamford, Conn.) will develop up to 20 cancer antigens. GZMO said it will receive $21 million in committed funding from Purdue, including a $12 million upfront payment, technol...